-
1
-
-
0021972684
-
The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells
-
October
-
Stein H., Mason D.Y., Gerdes J., et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985, 66(October (4)):848-858.
-
(1985)
Blood
, vol.66
, Issue.4
, pp. 848-858
-
-
Stein, H.1
Mason, D.Y.2
Gerdes, J.3
-
2
-
-
67649439764
-
Hepatosplenic T-cell lymphoma
-
IARC, Lyon, S.H. Swerdlow (Ed.)
-
Gaulard P., Jaffe E., Krenacs L., Macon W.R. Hepatosplenic T-cell lymphoma. WHO Classification of Tumours of hematopoietic and lymphoid tissues 2008, 292-293. IARC, Lyon. S.H. Swerdlow (Ed.).
-
(2008)
WHO Classification of Tumours of hematopoietic and lymphoid tissues
, pp. 292-293
-
-
Gaulard, P.1
Jaffe, E.2
Krenacs, L.3
Macon, W.R.4
-
3
-
-
0022105502
-
Lymphoid malignancies in Nebraska: a hypothesis
-
August
-
Weisenburger D.D. Lymphoid malignancies in Nebraska: a hypothesis. Nebr Med J 1985, 70(August (8)):300-305.
-
(1985)
Nebr Med J
, vol.70
, Issue.8
, pp. 300-305
-
-
Weisenburger, D.D.1
-
4
-
-
0026709610
-
Non-Hodgkin's lymphoma and occupational exposure
-
October
-
Scherr P.A., Hutchison G.B., Neiman R.S. Non-Hodgkin's lymphoma and occupational exposure. Cancer Res 1992, 52(October (19 Suppl.)):5503s-5509s.
-
(1992)
Cancer Res
, vol.52
, Issue.19 SUPPL.
-
-
Scherr, P.A.1
Hutchison, G.B.2
Neiman, R.S.3
-
5
-
-
0024991280
-
Environmental epidemiology of non-Hodgkin's lymphoma in eastern Nebraska
-
Weisenburger D.D. Environmental epidemiology of non-Hodgkin's lymphoma in eastern Nebraska. Am J Ind Med 1990, 18(3):303-305.
-
(1990)
Am J Ind Med
, vol.18
, Issue.3
, pp. 303-305
-
-
Weisenburger, D.D.1
-
6
-
-
0024989347
-
A case-control study of non-Hodgkin's lymphoma and the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) in eastern Nebraska
-
September
-
Zahm S.H., Weisenburger D.D., Babbitt P.A., Saal R.C. A case-control study of non-Hodgkin's lymphoma and the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) in eastern Nebraska. Epidemiology 1990, 1(September (5)):349-356.
-
(1990)
Epidemiology
, vol.1
, Issue.5
, pp. 349-356
-
-
Zahm, S.H.1
Weisenburger, D.D.2
Babbitt, P.A.3
Saal, R.C.4
-
7
-
-
0024421365
-
Occupation and lymphoid neoplasms
-
September
-
La Vecchia C., Negri E., D'Avanzo B., Franceschi S. Occupation and lymphoid neoplasms. Br J Cancer 1989, 60(September (3)):385-388.
-
(1989)
Br J Cancer
, vol.60
, Issue.3
, pp. 385-388
-
-
La Vecchia, C.1
Negri, E.2
D'Avanzo, B.3
Franceschi, S.4
-
8
-
-
3342957049
-
T-cell lymphoma in HIV-infected patients
-
August
-
Arzoo K.K., Bu X., Espina B.M., Seneviratne L., Nathwani B., Levine A.M. T-cell lymphoma in HIV-infected patients. J Acquir Immune Defic Syndr 2004, 36(August (5)):1020-1027.
-
(2004)
J Acquir Immune Defic Syndr
, vol.36
, Issue.5
, pp. 1020-1027
-
-
Arzoo, K.K.1
Bu, X.2
Espina, B.M.3
Seneviratne, L.4
Nathwani, B.5
Levine, A.M.6
-
9
-
-
0037481757
-
Bone involvement and abcess formation by neutrophil-rich CD30+ anaplastic large-cell lymphoma mimicking skeletal infection in an AIDS patient
-
Mira J.A., Fernández-Alonso J., Macías J., et al. Bone involvement and abcess formation by neutrophil-rich CD30+ anaplastic large-cell lymphoma mimicking skeletal infection in an AIDS patient. J Infect 2003.
-
(2003)
J Infect
-
-
Mira, J.A.1
Fernández-Alonso, J.2
Macías, J.3
-
10
-
-
0032908093
-
Peripheral T-cell lymphoma with Toutonlike tumor giant cells associated with HIV infection: report of two cases
-
May
-
Arber D.A., Chang K.L., Weiss L.M. Peripheral T-cell lymphoma with Toutonlike tumor giant cells associated with HIV infection: report of two cases. Am J Surg Pathol 1999, 23(May (5)):519-522.
-
(1999)
Am J Surg Pathol
, vol.23
, Issue.5
, pp. 519-522
-
-
Arber, D.A.1
Chang, K.L.2
Weiss, L.M.3
-
11
-
-
0034594369
-
Anaplastic large cell lymphoma (CD 30+), T-phenotype, in the heart of an HIV-positive man
-
January-February
-
Burke A.P., Andriko J.A., Virmani R. Anaplastic large cell lymphoma (CD 30+), T-phenotype, in the heart of an HIV-positive man. Cardiovasc Pathol 2000, 9(January-February (1)):49-52.
-
(2000)
Cardiovasc Pathol
, vol.9
, Issue.1
, pp. 49-52
-
-
Burke, A.P.1
Andriko, J.A.2
Virmani, R.3
-
12
-
-
66349108519
-
HIV-associated anaplastic large cell lymphoma: a report of three cases
-
September
-
Nava V.E., Cohen P., Kalan M., Ozdemirli M. HIV-associated anaplastic large cell lymphoma: a report of three cases. AIDS 2008, 22(September (14)):1892-1894.
-
(2008)
AIDS
, vol.22
, Issue.14
, pp. 1892-1894
-
-
Nava, V.E.1
Cohen, P.2
Kalan, M.3
Ozdemirli, M.4
-
13
-
-
0034554843
-
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features
-
[Review], December
-
Stein H., Foss H.D., Dürkop H., et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000, 96(December (12)):3681-3695. [Review].
-
(2000)
Blood
, vol.96
, Issue.12
, pp. 3681-3695
-
-
Stein, H.1
Foss, H.D.2
Dürkop, H.3
-
14
-
-
34249665451
-
Anaplastic large cell lymphoma
-
[Review], May
-
Medeiros L.J., Elenitoba-Johnson K.S. Anaplastic large cell lymphoma. Am J Clin Pathol 2007, 127(May (5)):707-722. [Review].
-
(2007)
Am J Clin Pathol
, vol.127
, Issue.5
, pp. 707-722
-
-
Medeiros, L.J.1
Elenitoba-Johnson, K.S.2
-
15
-
-
34547638047
-
Enomoto Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
-
[Epub 2007 Jul 11], August
-
Soda M., Choi Y.L. Enomoto Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448(August (7153)):561-566. [Epub 2007 Jul 11].
-
(2007)
Nature
, vol.448
, Issue.7153
, pp. 561-566
-
-
Soda, M.1
Choi, Y.L.2
-
16
-
-
61349164241
-
Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK
-
February
-
Grzelinski M., Steinberg F., Martens T., et al. Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK. Neoplasia 2009, 11(February (2)):145-156.
-
(2009)
Neoplasia
, vol.11
, Issue.2
, pp. 145-156
-
-
Grzelinski, M.1
Steinberg, F.2
Martens, T.3
-
17
-
-
0031035052
-
Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system
-
January
-
Iwahara T., Fujimoto J., Wen D. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene 1997, 14(January (4)):439-449.
-
(1997)
Oncogene
, vol.14
, Issue.4
, pp. 439-449
-
-
Iwahara, T.1
Fujimoto, J.2
Wen, D.3
-
18
-
-
54049149961
-
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
-
October
-
Janoueix-Lerosey I., Lequin D., Brugières L. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 2008, 455(October (7215)):967-970.
-
(2008)
Nature
, vol.455
, Issue.7215
, pp. 967-970
-
-
Janoueix-Lerosey, I.1
Lequin, D.2
Brugières, L.3
-
19
-
-
54049120220
-
Activating mutations in ALK provide a therapeutic target in neuroblastoma
-
October
-
George R.E., Sanda T., Hanna M., et al. Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature 2008, 455(October (7215)):975-978.
-
(2008)
Nature
, vol.455
, Issue.7215
, pp. 975-978
-
-
George, R.E.1
Sanda, T.2
Hanna, M.3
-
20
-
-
65549154968
-
Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma
-
March
-
Singh R.R., Cho-Vega J.H., Davuluri Y., et al. Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. Cancer Res 2009, 69(March (6)):2550-2558.
-
(2009)
Cancer Res
, vol.69
, Issue.6
, pp. 2550-2558
-
-
Singh, R.R.1
Cho-Vega, J.H.2
Davuluri, Y.3
-
21
-
-
0032521239
-
ALK-positive lymphoma: a single disease with a broad spectrum of morphology
-
March
-
Benharroch D., Meguerian-Bedoyan Z., Lamant L., et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 1998, 91(March (6)):2076-2084.
-
(1998)
Blood
, vol.91
, Issue.6
, pp. 2076-2084
-
-
Benharroch, D.1
Meguerian-Bedoyan, Z.2
Lamant, L.3
-
22
-
-
0031689795
-
ALK expression defines a distinct group of T/null lymphomas (" ALK lymphomas" ) with a wide morphological spectrum
-
September
-
Falini B., Bigerna B., Fizzotti M., et al. ALK expression defines a distinct group of T/null lymphomas (" ALK lymphomas" ) with a wide morphological spectrum. Am J Pathol 1998, 153(September (3)):875-886.
-
(1998)
Am J Pathol
, vol.153
, Issue.3
, pp. 875-886
-
-
Falini, B.1
Bigerna, B.2
Fizzotti, M.3
-
23
-
-
0030970804
-
Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type
-
April
-
Pileri S.A., Pulford K., Mori S. Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type. Am J Pathol 1997, 150(April (4)):1207-1211.
-
(1997)
Am J Pathol
, vol.150
, Issue.4
, pp. 1207-1211
-
-
Pileri, S.A.1
Pulford, K.2
Mori, S.3
-
24
-
-
33645228963
-
ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases
-
February
-
Vassallo J., Lamant L., Brugieres L. ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases. Am J Surg Pathol 2006, 30(February (2)):223-229.
-
(2006)
Am J Surg Pathol
, vol.30
, Issue.2
, pp. 223-229
-
-
Vassallo, J.1
Lamant, L.2
Brugieres, L.3
-
25
-
-
33748861223
-
From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation
-
September
-
Soumelis V., Liu Y.J. From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation. Eur J Immunol 2006, 36(September (9)):2286-2292.
-
(2006)
Eur J Immunol
, vol.36
, Issue.9
, pp. 2286-2292
-
-
Soumelis, V.1
Liu, Y.J.2
-
26
-
-
0034554843
-
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features
-
December
-
Stein H., Foss H.D., Dürkop H. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000, 96(December (12)):3681-3695.
-
(2000)
Blood
, vol.96
, Issue.12
, pp. 3681-3695
-
-
Stein, H.1
Foss, H.D.2
Dürkop, H.3
-
27
-
-
0029803574
-
Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules
-
November
-
Foss H.D., Anagnostopoulos I., Araujo I. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 1996, 88(November (10)):4005-4011.
-
(1996)
Blood
, vol.88
, Issue.10
, pp. 4005-4011
-
-
Foss, H.D.1
Anagnostopoulos, I.2
Araujo, I.3
-
28
-
-
0030944428
-
Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin
-
February
-
Krenacs L., Wellmann A., Sorbara L. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood 1997, 89(February (3)):980-989.
-
(1997)
Blood
, vol.89
, Issue.3
, pp. 980-989
-
-
Krenacs, L.1
Wellmann, A.2
Sorbara, L.3
-
29
-
-
0030034745
-
High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining
-
January
-
Lamant L., Meggetto F., al Saati T., et al. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood 1996, 87(January (1)):284-291.
-
(1996)
Blood
, vol.87
, Issue.1
, pp. 284-291
-
-
Lamant, L.1
Meggetto, F.2
al Saati, T.3
-
30
-
-
0025139773
-
CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35
-
February
-
Mason D.Y., Bastard C., Rimokh R., et al. CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35. Br J Haematol 1990, 74(February (2)):161-168.
-
(1990)
Br J Haematol
, vol.74
, Issue.2
, pp. 161-168
-
-
Mason, D.Y.1
Bastard, C.2
Rimokh, R.3
-
31
-
-
0028198206
-
Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma
-
Erratum in: Science 1995;267(January (5196)):316-317, March
-
Morris S.W., Kirstein M.N., Valentine M.B., et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994, 263(March (5151)):1281-1284. Erratum in: Science 1995;267(January (5196)):316-317.
-
(1994)
Science
, vol.263
, Issue.5151
, pp. 1281-1284
-
-
Morris, S.W.1
Kirstein, M.N.2
Valentine, M.B.3
-
32
-
-
0027194670
-
High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children
-
August
-
Brousset P., Rochaix P., Chittal S., et al. High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children. Histopathology 1993, 23(August (2)):189-191.
-
(1993)
Histopathology
, vol.23
, Issue.2
, pp. 189-191
-
-
Brousset, P.1
Rochaix, P.2
Chittal, S.3
-
33
-
-
38949116321
-
Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas
-
March
-
Salaverria I., Beà S., Lopez-Guillermo A., et al. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas. Br J Haematol 2008, 140(March (5)):516-526.
-
(2008)
Br J Haematol
, vol.140
, Issue.5
, pp. 516-526
-
-
Salaverria, I.1
Beà, S.2
Lopez-Guillermo, A.3
-
34
-
-
33847406330
-
Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes
-
[Epub 2006 Oct 31], March
-
Lamant L., de Reyniès A., Duplantier M.M. Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes. Blood 2007, 109(March (5)):2156-2164. [Epub 2006 Oct 31].
-
(2007)
Blood
, vol.109
, Issue.5
, pp. 2156-2164
-
-
Lamant, L.1
de Reyniès, A.2
Duplantier, M.M.3
-
35
-
-
20144385625
-
Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas
-
May
-
Thompson M.A., Stumph J., Henrickson S.E., et al. Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas. Hum Pathol 2005, 36(May (5)):494-504.
-
(2005)
Hum Pathol
, vol.36
, Issue.5
, pp. 494-504
-
-
Thompson, M.A.1
Stumph, J.2
Henrickson, S.E.3
-
36
-
-
77951906200
-
Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms
-
[Epub 2010 Feb 16], March
-
Piva R., Agnelli L., Pellegrino E., et al. Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol 2010, 28(March (9)):1583-1590. [Epub 2010 Feb 16].
-
(2010)
J Clin Oncol
, vol.28
, Issue.9
, pp. 1583-1590
-
-
Piva, R.1
Agnelli, L.2
Pellegrino, E.3
-
37
-
-
47049084821
-
ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project
-
[Epub 2008 Apr 2], June
-
Savage K.J., Harris N.L., Vose J.M., et al. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 2008, 111(June (12)):5496-5504. [Epub 2008 Apr 2].
-
(2008)
Blood
, vol.111
, Issue.12
, pp. 5496-5504
-
-
Savage, K.J.1
Harris, N.L.2
Vose, J.M.3
-
38
-
-
0033570945
-
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK
-
November
-
Falini B., Pulford K., Pucciarini A., et al. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood 1999, 94(November (10)):3509-3515.
-
(1999)
Blood
, vol.94
, Issue.10
, pp. 3509-3515
-
-
Falini, B.1
Pulford, K.2
Pucciarini, A.3
-
39
-
-
20844443468
-
WHO-EORTC classification for cutaneous lymphomas
-
May
-
Willemze R., Jaffe E.S., Burg G., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005, 105(May (10)):3768-3785.
-
(2005)
Blood
, vol.105
, Issue.10
, pp. 3768-3785
-
-
Willemze, R.1
Jaffe, E.S.2
Burg, G.3
-
40
-
-
0028836518
-
Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance
-
January
-
Fraga M., Brousset P., Schlaifer D. Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance. Am J Clin Pathol 1995, 103(January (1)):82-89.
-
(1995)
Am J Clin Pathol
, vol.103
, Issue.1
, pp. 82-89
-
-
Fraga, M.1
Brousset, P.2
Schlaifer, D.3
-
41
-
-
0015150080
-
Report of the Committee on Hodgkin's Disease Staging Classification
-
November
-
Carbone P.P., Kaplan H.S., Musshoff K. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971, 31(November (11)):1860-1861.
-
(1971)
Cancer Res
, vol.31
, Issue.11
, pp. 1860-1861
-
-
Carbone, P.P.1
Kaplan, H.S.2
Musshoff, K.3
-
42
-
-
34848892107
-
FDG-PET in T-cell and NK-cell neoplasms
-
[Epub 2007 Aug 22], October
-
Kako S., Izutsu K., Ota Y., et al. FDG-PET in T-cell and NK-cell neoplasms. Ann Oncol 2007, 18(October (10)):1685-1690. [Epub 2007 Aug 22].
-
(2007)
Ann Oncol
, vol.18
, Issue.10
, pp. 1685-1690
-
-
Kako, S.1
Izutsu, K.2
Ota, Y.3
-
43
-
-
46949093658
-
Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies
-
[Epub 2008 May 29], August
-
Khong P.L., Pang C.B., Liang R., et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies. Ann Hematol 2008, 87(August (8)):613-621. [Epub 2008 May 29].
-
(2008)
Ann Hematol
, vol.87
, Issue.8
, pp. 613-621
-
-
Khong, P.L.1
Pang, C.B.2
Liang, R.3
-
44
-
-
6944238457
-
Towards understanding the peripheral T-cell lymphomas
-
October
-
Armitage J.O., Vose J.M., Weisenburger D.D. Towards understanding the peripheral T-cell lymphomas. Ann Oncol 2004, 15(October (10)):1447-1449.
-
(2004)
Ann Oncol
, vol.15
, Issue.10
, pp. 1447-1449
-
-
Armitage, J.O.1
Vose, J.M.2
Weisenburger, D.D.3
-
45
-
-
0033967199
-
Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children-a report from the French Society of Pediatric Oncology
-
January
-
Brugières L., Quartier P., Le Deley M.C. Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children-a report from the French Society of Pediatric Oncology. Ann Oncol 2000, 11(January (1)):53-58.
-
(2000)
Ann Oncol
, vol.11
, Issue.1
, pp. 53-58
-
-
Brugières, L.1
Quartier, P.2
Le Deley, M.C.3
-
46
-
-
0030822414
-
Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome
-
November
-
Tilly H., Gaulard P., Lepage E., et al. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood 1997, 90(November (9)):3727-3734.
-
(1997)
Blood
, vol.90
, Issue.9
, pp. 3727-3734
-
-
Tilly, H.1
Gaulard, P.2
Lepage, E.3
-
47
-
-
0030447574
-
Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients
-
November
-
Zinzani P.L., Bendandi M., Visani G. Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients. Leuk Lymphoma 1996, 23(November (5-6)):577-582.
-
(1996)
Leuk Lymphoma
, vol.23
, Issue.5-6
, pp. 577-582
-
-
Zinzani, P.L.1
Bendandi, M.2
Visani, G.3
-
48
-
-
12144287463
-
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study
-
[Epub 2003 Nov 26], April
-
Gallamini A., Stelitano C., Calvi, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004, 103(April (7)):2474-2479. [Epub 2003 Nov 26].
-
(2004)
Blood
, vol.103
, Issue.7
, pp. 2474-2479
-
-
Gallamini, A.1
Stelitano, C.2
Calvi3
-
49
-
-
0034329288
-
Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype
-
November
-
Suzuki R., Kagami Y., Takeuchi K., et al. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype. Blood 2000, 96(November (9)):2993-3000.
-
(2000)
Blood
, vol.96
, Issue.9
, pp. 2993-3000
-
-
Suzuki, R.1
Kagami, Y.2
Takeuchi, K.3
-
50
-
-
78951475992
-
Prognostic factors and long term outcome of 138 adults with systemic anaplastic large-cell lymphoma: a retrospective study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA)
-
[abstract 322]
-
Sibon D., Fournier M., Briere J., et al. Prognostic factors and long term outcome of 138 adults with systemic anaplastic large-cell lymphoma: a retrospective study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA). Blood 2010, [abstract 322].
-
(2010)
Blood
-
-
Sibon, D.1
Fournier, M.2
Briere, J.3
-
51
-
-
0031900563
-
Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients
-
April
-
Zinzani P.L., Pileri S., Bendandi M., et al. Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients. J Clin Oncol 1998, 16(April (4)):1532-1537.
-
(1998)
J Clin Oncol
, vol.16
, Issue.4
, pp. 1532-1537
-
-
Zinzani, P.L.1
Pileri, S.2
Bendandi, M.3
-
52
-
-
0029094514
-
Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity
-
September
-
Shiota M., Nakamura S., Ichinohasama R., et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood 1995, 86(September (5)):1954-1960.
-
(1995)
Blood
, vol.86
, Issue.5
, pp. 1954-1960
-
-
Shiota, M.1
Nakamura, S.2
Ichinohasama, R.3
-
53
-
-
0033151520
-
Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma
-
June
-
Gascoyne R.D., Aoun P., Wu D., et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999, 93(June (11)):3913-3921.
-
(1999)
Blood
, vol.93
, Issue.11
, pp. 3913-3921
-
-
Gascoyne, R.D.1
Aoun, P.2
Wu, D.3
-
54
-
-
78650336216
-
C-MYC rearrangement may induce an aggressive phenotype in anaplastic lymphoma kinase positive anaplastic large cell lymphoma: Identification of a novel fusion gene ALO17/C-MYC
-
January
-
Moritake H., Shimonodan H., Marutsuka K., et al. C-MYC rearrangement may induce an aggressive phenotype in anaplastic lymphoma kinase positive anaplastic large cell lymphoma: Identification of a novel fusion gene ALO17/C-MYC. Am J Hematol 2011, 86(January (1)):75-78.
-
(2011)
Am J Hematol
, vol.86
, Issue.1
, pp. 75-78
-
-
Moritake, H.1
Shimonodan, H.2
Marutsuka, K.3
-
55
-
-
0032533908
-
CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology
-
November
-
Brugières L., Deley M.C., Pacquement H., et al. CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood 1998, 92(November (10)):3591-3598.
-
(1998)
Blood
, vol.92
, Issue.10
, pp. 3591-3598
-
-
Brugières, L.1
Deley, M.C.2
Pacquement, H.3
-
56
-
-
0032147217
-
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy
-
August
-
Zinzani P.L., Martelli M., Magagnoli M. Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy. Blood 1998, 92(August (3)):790-794.
-
(1998)
Blood
, vol.92
, Issue.3
, pp. 790-794
-
-
Zinzani, P.L.1
Martelli, M.2
Magagnoli, M.3
-
57
-
-
0035086808
-
Long-term results with MACOP-B and radiation therapy for aggressive lymphomas
-
February
-
Krieger G., Kreysing E., Kneba M. Long-term results with MACOP-B and radiation therapy for aggressive lymphomas. Onkologie 2001, 24(February (Suppl. 1)):49-58.
-
(2001)
Onkologie
, vol.24
, Issue.SUPPL. 1
, pp. 49-58
-
-
Krieger, G.1
Kreysing, E.2
Kneba, M.3
-
58
-
-
58949083548
-
Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941
-
March
-
Lowe E.J., Sposto R., Perkins S.L., et al. Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941. Pediatr Blood Cancer 2009, 52(March (3)):335-339.
-
(2009)
Pediatr Blood Cancer
, vol.52
, Issue.3
, pp. 335-339
-
-
Lowe, E.J.1
Sposto, R.2
Perkins, S.L.3
-
59
-
-
0033854009
-
Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial
-
June
-
Deconinck E., Lamy T., Foussard C., et al. Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial. Br J Haematol 2000, 109(June (4)):736-742.
-
(2000)
Br J Haematol
, vol.109
, Issue.4
, pp. 736-742
-
-
Deconinck, E.1
Lamy, T.2
Foussard, C.3
-
60
-
-
33747596427
-
Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation
-
[Epub 2006 Jul 27], September
-
Corradini P., Tarella C., Zallio F., et al. Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia 2006, 20(September (9)):1533-1538. [Epub 2006 Jul 27].
-
(2006)
Leukemia
, vol.20
, Issue.9
, pp. 1533-1538
-
-
Corradini, P.1
Tarella, C.2
Zallio, F.3
-
61
-
-
43049095718
-
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma
-
[Epub 2008 Feb 25], May
-
Mercadal S., Briones J., Xicoy B., et al. Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma. Ann Oncol 2008, 19(May (5)):958-963. [Epub 2008 Feb 25].
-
(2008)
Ann Oncol
, vol.19
, Issue.5
, pp. 958-963
-
-
Mercadal, S.1
Briones, J.2
Xicoy, B.3
-
62
-
-
34249065028
-
New treatment concepts in diffuse large B-cell lymphomas (DLBL): chemothe-rapy and biological therapy
-
May
-
Rodriguez J., Gutierrez A. New treatment concepts in diffuse large B-cell lymphomas (DLBL): chemothe-rapy and biological therapy. Rev Recent Clin Trials 2007, 2(May (2)):149-162.
-
(2007)
Rev Recent Clin Trials
, vol.2
, Issue.2
, pp. 149-162
-
-
Rodriguez, J.1
Gutierrez, A.2
-
63
-
-
0025957150
-
PARMA international protocol: pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients)
-
January
-
Philip T., Chauvin F., Bron D., et al. PARMA international protocol: pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients). Ann Oncol 1991, 2(January (Suppl. 1)):57-64.
-
(1991)
Ann Oncol
, vol.2
, Issue.SUPPL. 1
, pp. 57-64
-
-
Philip, T.1
Chauvin, F.2
Bron, D.3
-
64
-
-
0037355624
-
Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype
-
March
-
Song K.W., Mollee P., Keating A., Crump M. Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype. Br J Haematol 2003, 120(March (6)):978-985.
-
(2003)
Br J Haematol
, vol.120
, Issue.6
, pp. 978-985
-
-
Song, K.W.1
Mollee, P.2
Keating, A.3
Crump, M.4
-
65
-
-
8644231731
-
Histology impacts the outcome of peripheral T-cell lymphomas after high dose chemotherapy and stem cell transplant
-
November
-
Jagasia M., Morgan D., Goodman S., et al. Histology impacts the outcome of peripheral T-cell lymphomas after high dose chemotherapy and stem cell transplant. Leuk Lymphoma 2004, 45(November (11)):2261-2267.
-
(2004)
Leuk Lymphoma
, vol.45
, Issue.11
, pp. 2261-2267
-
-
Jagasia, M.1
Morgan, D.2
Goodman, S.3
-
66
-
-
44249097064
-
Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire
-
[Epub 2008 Apr 7], May
-
Le Gouill S., Milpied N., Buzyn A., et al. Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire. J Clin Oncol 2008, 26(May (14)):2264-2271. [Epub 2008 Apr 7].
-
(2008)
J Clin Oncol
, vol.26
, Issue.14
, pp. 2264-2271
-
-
Le Gouill, S.1
Milpied, N.2
Buzyn, A.3
-
67
-
-
2942677243
-
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells
-
June
-
Corradini P., Dodero A., Zallio F. Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol 2004, 22(June (11)):2172-2176.
-
(2004)
J Clin Oncol
, vol.22
, Issue.11
, pp. 2172-2176
-
-
Corradini, P.1
Dodero, A.2
Zallio, F.3
-
68
-
-
33645079219
-
Successful treatment with allogeneic bone marrow transplantation of an early relapse of ALK-positive anaplastic large cell lymphoma
-
Bordon V., De Paepe P., Dhooge C., et al. Successful treatment with allogeneic bone marrow transplantation of an early relapse of ALK-positive anaplastic large cell lymphoma. Haematologica 2005, 90(3).
-
(2005)
Haematologica
, vol.90
, Issue.3
-
-
Bordon, V.1
De Paepe, P.2
Dhooge, C.3
-
69
-
-
67651230261
-
Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets
-
Rodríguez J., Gutiérrez A., Martínez-Delgado B., Perez-Manga G. Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets. Crit Rev Oncol Hematol 2009, 71(3):181-198.
-
(2009)
Crit Rev Oncol Hematol
, vol.71
, Issue.3
, pp. 181-198
-
-
Rodríguez, J.1
Gutiérrez, A.2
Martínez-Delgado, B.3
Perez-Manga, G.4
-
70
-
-
34447573999
-
Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma
-
July
-
Ansell S.M., Horwitz S.M., Engert A., et al. Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma. J Clin Oncol 2007, 25(July (19)):2764-2769.
-
(2007)
J Clin Oncol
, vol.25
, Issue.19
, pp. 2764-2769
-
-
Ansell, S.M.1
Horwitz, S.M.2
Engert, A.3
-
71
-
-
0242579150
-
The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma
-
November
-
Borchmann P., Treml J.F., Hansen H. The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma. Blood 2003, 102(November (10)):3737-3742.
-
(2003)
Blood
, vol.102
, Issue.10
, pp. 3737-3742
-
-
Borchmann, P.1
Treml, J.F.2
Hansen, H.3
-
72
-
-
76749151760
-
Phase I study of an anti-CD30 Fc engineered humanized monoclonal antibody in Hodgkin lymphoma (HL) or anaplastic large cell lymphoma (ALCL) patients: Safety, pharmacokinetics (PK), immunogenicity, and efficacy
-
[abstract 8531]
-
Blum K.A., Smith M., Fung H., et al. Phase I study of an anti-CD30 Fc engineered humanized monoclonal antibody in Hodgkin lymphoma (HL) or anaplastic large cell lymphoma (ALCL) patients: Safety, pharmacokinetics (PK), immunogenicity, and efficacy. J Clin Oncol 2009, 27:15s. [abstract 8531].
-
(2009)
J Clin Oncol
, vol.27
-
-
Blum, K.A.1
Smith, M.2
Fung, H.3
-
73
-
-
0036285666
-
A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma
-
Schnell R., Staak O., Borchmann P., et al. A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma. Clin Cancer Res 2002.
-
(2002)
Clin Cancer Res
-
-
Schnell, R.1
Staak, O.2
Borchmann, P.3
-
74
-
-
78049515807
-
Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas
-
November
-
Younes A., Bartlett N.L., Leonard J.P. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. N Engl J Med 2010, 363(November (19)):1812-1821.
-
(2010)
N Engl J Med
, vol.363
, Issue.19
, pp. 1812-1821
-
-
Younes, A.1
Bartlett, N.L.2
Leonard, J.P.3
-
75
-
-
78951471865
-
Complete remissions with brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large cell lymphoma
-
[abstract 961]
-
Shustov A.R., Advani R., Brice P., et al. Complete remissions with brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large cell lymphoma. Blood 2010, [abstract 961].
-
(2010)
Blood
-
-
Shustov, A.R.1
Advani, R.2
Brice, P.3
-
76
-
-
44849126091
-
Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors
-
May
-
McDermott U., Iafrate A.J., Gray N.S., et al. Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors. Cancer Res 2008, 68(May (9)):3389-3395.
-
(2008)
Cancer Res
, vol.68
, Issue.9
, pp. 3389-3395
-
-
McDermott, U.1
Iafrate, A.J.2
Gray, N.S.3
-
77
-
-
78049428879
-
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor
-
October
-
Butrynski J.E., D'Adamo D.R., Hornick J.L., et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med 2010, 363(October (18)):1727-1733.
-
(2010)
N Engl J Med
, vol.363
, Issue.18
, pp. 1727-1733
-
-
Butrynski, J.E.1
D'Adamo, D.R.2
Hornick, J.L.3
-
78
-
-
44949166624
-
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination
-
June
-
Chiarle R., Martinengo C., Mastini C., et al. The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination. Nat Med 2008, 14(June (6)):676-680.
-
(2008)
Nat Med
, vol.14
, Issue.6
, pp. 676-680
-
-
Chiarle, R.1
Martinengo, C.2
Mastini, C.3
|